| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.3 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.3 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.3 |